Comparative Evaluation of the New HIV VIDAS® DUO AG/AB Assay With DUO Ultra on Well Characterized Participants From the HIV‐1 Acute Infection French ANRS PRIMO Cohort
Journal of Medical Virology · 2026
DOI: 10.1002/jmv.70953 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Gilbert Mchantaf und 11 weiteren Autor:innen. Beteiligte Einrichtung: CHU d'Orléans, Virologie, Orléans, France. Hauptthemen laut MEDLINE: HIV Antibodies, HIV Antigens, HIV Core Protein p24, HIV Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ANRS-MIE.
Abstract (Originalsprache)
Diagnosing HIV‐1 infection as early as the primary infection is crucial. In this context, we performed a comparative evaluation and agreement analysis of the newly proposed serological assay for the combined detection of total antibodies against HIV and P24 antigen (HIV VIDAS® DUO AG/AB, bioMérieux®), with the previously available HIV VIDAS® DUO Ultra assay in the well characterized acute‐HIV‐infection multicentric ANRS‐CO‐06‐PRIMO Cohort in classification of Fiebig stages combined with confirmatory testing. Samples collected on the day of enrollment in the cohort, between April 2024 and June 2025, were analyzed with both serological assays. We also performed a recency infection assay, an HIV‐1 westernblotting and the measurement of HIV‐RNA. Acute infection was classified according to Fiebig stages and compared between both assays. All samples ( n = 77) were positive with both assays. One major discordance was noted, with a positive antigen and a negative antibody reaction with DUO AG/AB, with an opposite configuration with DUO Ultra. A high proportion of not determinable signals (26% to 68%) was noted with both assays, prompting a difficulty in classifying acute infection stages in the absence of confirmatory assays. The high rate of not determinable signals especially with P24 antigen with both assays demonstrated in our study, could prompt a difficulty in acute infection classification according to Fiebig.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CHU d'Orléans, Virologie, Orléans, France.
- Université d'Orléans, LI2RSO, Orléans, France.
- AP-HP, Hôpital Bicêtre, Santé Publique, Paris, France.
- INSERM CESP U1018, Université Paris Saclay, Paris, France.
- Université de Tours, INSERM U1259, CHRU de Tours, Tours, France.
- CHU d'Orléans, service des maladies infectieuses et tropicales, Orléans, France.
ORCID-Profile: Gilbert Mchantaf, Karl Stefic, Laurent Hocqueloux
Förderung
- ANRS-MIE
Zitieren
APA
Mchantaf, G., Maia, X., Andriantsoanirina, V., Dehan, O., Stefic, K., Hocqueloux, L., Robineau, O., Makinson, A., Goujard, C., Meyer, L., Avettand-Fenoel, V., & ANRS PRIMO cohort (2026). Comparative Evaluation of the New HIV VIDAS® DUO AG/AB Assay With DUO Ultra on Well Characterized Participants From the HIV‐1 Acute Infection French ANRS PRIMO Cohort. Journal of Medical Virology. https://doi.org/10.1002/jmv.70953
Vancouver
Mchantaf G, Maia X, Andriantsoanirina V, Dehan O, Stefic K, Hocqueloux L, et al. Comparative Evaluation of the New HIV VIDAS® DUO AG/AB Assay With DUO Ultra on Well Characterized Participants From the HIV‐1 Acute Infection French ANRS PRIMO Cohort. Journal of Medical Virology. 2026. doi:10.1002/jmv.70953
BibTeX
@article{Mchantaf2026,
author = {Mchantaf, Gilbert and Maia, Xavier and Andriantsoanirina, Valérie and Dehan, Océane and Stefic, Karl and Hocqueloux, Laurent and Robineau, Olivier and Makinson, Alain and Goujard, Cécile and Meyer, Laurence and Avettand-Fenoel, Véronique and ANRS PRIMO cohort, ANRS PRIMO cohort},
title = {Comparative Evaluation of the New HIV VIDAS® DUO AG/AB Assay With DUO Ultra on Well Characterized Participants From the HIV‐1 Acute Infection French ANRS PRIMO Cohort},
journal = {Journal of Medical Virology},
year = {2026},
doi = {10.1002/jmv.70953}
}
EUVIMED